PM

Pranshu Mistry

Active Director Director DIN 10894593
DIN 10894593 First appointment Jan 2025 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value •••• Premium profile

About Pranshu Mistry

Data last updated:

Pranshu Mistry is a Director at Ambica Pharma Machines Private Limited (since 2025). The company operates in Healthcare. Ambica Pharma Machines Private Limited reported revenue of ₹17.47 Cr (FY 2024).

DIN 10894593
Primary Designation Director
Industry Healthcare
First Appointment 07 Jan 2025
Oldest Company Age 20 yrs
Largest company Ambica Pharma Machines Private Limited · ₹17.47 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Jan 20252006₹17.47 Cr (FY 2024)Active

Board colleagues of Pranshu Mistry

Directorship timeline

Open interactive timeline →
Ambica Pharma Machines Private Limited
Premium access

Shareholding and investment profile for Pranshu Mistry

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Pranshu Mistry

Pranshu Mistry currently holds 1 directorship: Ambica Pharma Machines Private Limited (Director, since 07 Jan 2025, revenue ₹17.47 Cr (FY 2024)).

Pranshu Mistry was first appointed on 07 Jan 2025 as Director at Ambica Pharma Machines Private Limited.

The current boards of Pranshu Mistry's companies include Ashok Kalidas Mistry (Ambica Pharma Machines Private Limited), Manaswi Ashok Mistry (Ambica Pharma Machines Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available